Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Pre-Market Session

Author: Benzinga Insights | March 27, 2023 09:06am

Gainers

  • Cyclerion Therapeutics (NASDAQ:CYCN) stock rose 33.6% to $0.58 during Monday's pre-market session. The company's market cap stands at $25.3 million. The company's, Q4 earnings came out 3 days ago.
  • Adial Pharmaceuticals (NASDAQ:ADIL) stock moved upwards by 21.8% to $0.43. The company's market cap stands at $12.2 million.
  • Healthcare Triangle (NASDAQ:HCTI) shares moved upwards by 17.34% to $0.49. The company's market cap stands at $20.2 million.
  • Pyxis Oncology (NASDAQ:PYXS) stock moved upwards by 15.83% to $2.56. The company's market cap stands at $94.6 million. As per the news, the Q4 earnings report came out 3 days ago.
  • Coeptis Therapeutics (NASDAQ:COEP) shares increased by 14.86% to $1.7. The market value of their outstanding shares is at $8.6 million.
  • Lantern Pharma (NASDAQ:LTRN) stock moved upwards by 14.06% to $5.15. The market value of their outstanding shares is at $55.9 million.

Losers

  • Unity Biotechnology (NASDAQ:UBX) stock fell 45.8% to $2.25 during Monday's pre-market session. The market value of their outstanding shares is at $32.2 million.
  • NuCana (NASDAQ:NCNA) stock decreased by 31.46% to $0.85. The company's market cap stands at $44.3 million.
  • Nymox Pharmaceutical (NASDAQ:NYMX) shares declined by 20.25% to $0.32. The market value of their outstanding shares is at $28.6 million.
  • Pharming (NASDAQ:PHAR) stock fell 17.05% to $12.41. The company's market cap stands at $809.6 million.
  • Sonnet BioTherapeutics (NASDAQ:SONN) stock declined by 10.66% to $0.55. The market value of their outstanding shares is at $11.0 million.
  • Pear Therapeutics (NASDAQ:PEAR) stock decreased by 10.12% to $0.26. The company's market cap stands at $36.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADIL COEP CYCN HCTI LTRN NCNA NYMX PEAR PHAR PYXS SONN UBX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist